Thu, April 27, 2023
Wed, April 26, 2023
Tue, April 25, 2023

Sumant Kulkarni Initiated (STOK) at Strong Buy and Held Target at $24 on, Apr 26th, 2023

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -buy-and-held-target-at-24-on-apr-26th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication
Sumant Kulkarni of Canaccord Genuity, Initiated "Stoke Therapeutics, Inc." (STOK) at Strong Buy and Held Target at $24 on, Apr 26th, 2023.

Sumant has made no other calls on STOK in the last 4 months.



There are 5 other peers that have a rating on STOK. Out of the 5 peers that are also analyzing STOK, 0 agree with Sumant's Rating of Hold.



These are the ratings of the 5 analyists that currently disagree with Sumant


  • Joseph Stringer of "Needham" Reiterated at Strong Buy and Held Target at $25 on, Thursday, March 16th, 2023
  • Judah Frommer of "Credit Suisse" Maintained at Buy with Decreased Target to $28 on, Tuesday, March 7th, 2023
  • Laura Chico of "Wedbush" Maintained at Buy with Decreased Target to $25 on, Tuesday, March 7th, 2023
  • Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $35 on, Tuesday, March 7th, 2023
  • Charles Duncan of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $20 on, Tuesday, March 7th, 2023